FTXH Among Health Care ETFs
End-of-day Nov 19, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.3% | −4.7% | −1.6% | −0.4% | +28.3% | +32.9% | +79.3% | +65.9% | +151.4% | +132.9% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$82 of every $1,000 in FTXH is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly and Company | Healthcare | 8.23% | $823.34 | 64K | $89.1M |
| 2 | ABBVAbbVie | Healthcare | 7.68% | $768.22 | 291K | $83.2M |
| 3 | JNJJohnson & Johnson | Healthcare | 7.06% | $706.48 | 280K | $76.5M |
| 4 | PFEPfizer | Healthcare | 6.79% | $679.06 | 2.6M | $73.5M |
| 5 | MRKMerck | Healthcare | 6.42% | $642.23 | 505K | $69.5M |
| 6 | VTRSViatris | Healthcare | 4.23% | $423.01 | 2.3M | $45.8M |
| 7 | REGNRegeneron Pharmaceuticals | Healthcare | 4.07% | $407.46 | 47K | $44.1M |
| 8 | BIIBBiogen | Healthcare | 4.00% | $399.63 | 172K | $43.3M |
| 9 | GILDGilead Sciences | Healthcare | 3.98% | $397.66 | 255K | $43.0M |
| 10 | ZTSZoetis | Healthcare | 3.82% | $382.21 | 484K | $41.4M |
| 11 | AMGNAmgen | Healthcare | 3.56% | $355.61 | 87K | $38.5M |
| 12 | UTHRUnited Therapeutics | Healthcare | 3.46% | $345.81 | 65K | $37.4M |
| 13 | VRTXVertex Pharmaceuticals Incorporated | Healthcare | 3.39% | $339.27 | 68K | $36.7M |
| 14 | INCYIncyte | Healthcare | 3.26% | $325.55 | 299K | $35.2M |
| 15 | BMYBristol-Myers Squibb Company | Healthcare | 3.07% | $307.00 | 558K | $33.2M |
of the $110B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 8.23% |
| 2 | ABBV | AbbVie | 7.68% |
| 3 | JNJ | Johnson & Johnson | 7.06% |
| 4 | PFE | Pfizer | 6.79% |
| 5 | MRK | Merck & | 6.42% |
| 6 | VTRS | Viatris | 4.23% |
| 7 | REGN | Regeneron Pharmaceuticals | 4.07% |
| 8 | BIIB | Biogen | 4.00% |
| 9 | GILD | Gilead Sciences | 3.98% |
| 10 | ZTS | Zoetis | 3.82% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 24, 2026 | Sep 30, 2026 | $0.0113 |
| Jun 25, 2026 | Jun 30, 2026 | $0.0920 |
| Mar 26, 2026 | Mar 31, 2026 | $0.0573 |
| Dec 12, 2025 | Dec 31, 2025 | $0.13 |
| Sep 25, 2025 | Sep 30, 2025 | $0.15 |
| Jun 26, 2025 | Jun 30, 2025 | $0.0892 |
| Mar 27, 2025 | Mar 31, 2025 | $0.0992 |
| Dec 13, 2024 | Dec 31, 2024 | $0.13 |
| Sep 26, 2024 | Sep 30, 2024 | $0.12 |
| Jun 27, 2024 | Jun 28, 2024 | $0.13 |
| Mar 21, 2024 | Mar 28, 2024 | $0.0676 |
| Dec 22, 2023 | Dec 29, 2023 | $0.12 |